Table 2.
6 months |
1 year |
2 years |
|||||||
---|---|---|---|---|---|---|---|---|---|
MSD (n = 104) |
UCBT (n = 41) |
p | MSD (n = 98) |
UCBT (n = 40) |
p | MSD (n = 90) |
UCBT (n = 36) |
p | |
CR + PR | 81 (78%) | 32 (78%) | 0.98 | 68 (69%) | 29 (73%) | 0.72 | 60 (67%) | 24 (67%) | 0.99 |
CR | 1 (1%) | 2 (5%) | 0.19 | 5 (5%) | 4 (10%) | 0.28 | 11 (14%) | 11 (33%) | 0.02 |
Other | 23 (22%) | 9 (22%) | 30 (31%) | 11 (28%) | 30 (33%) | 12 (33%) |
Other includes following: mixed response, flare, progression, death or relapse of underlying malignancy.
MSD matched sibling donor, UCBT umbilical cord blood transplant, CR complete response, PR partial response